Report Detail
Global (United States, European Union and China) Sevelamer Market Research Report 2019-2025
- RnM3603847 |
- 19 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
In 2019, the market size of Sevelamer is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sevelamer.
This report studies the global market size of Sevelamer, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sevelamer sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
...
Market Segment by Product Type
Tablet
Oral suspension
Market Segment by Application
Adult
Pediatric
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Sevelamer status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sevelamer manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Sevelamer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Sevelamer Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Tablet
- 1.3.3 Oral suspension
- 1.4 Market Segment by Application
- 1.4.1 Global Sevelamer Market Share by Application (2019-2025)
- 1.4.2 Adult
- 1.4.3 Pediatric
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Sevelamer Market Size
- 2.1.1 Global Sevelamer Revenue 2014-2025
- 2.1.2 Global Sevelamer Sales 2014-2025
- 2.2 Sevelamer Growth Rate by Regions
- 2.2.1 Global Sevelamer Sales by Regions 2014-2019
- 2.2.2 Global Sevelamer Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Sevelamer Sales by Manufacturers
- 3.1.1 Sevelamer Sales by Manufacturers 2014-2019
- 3.1.2 Sevelamer Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Sevelamer Revenue by Manufacturers (2014-2019)
- 3.2.2 Sevelamer Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Sevelamer Market Concentration Ratio (CR5 and HHI)
- 3.3 Sevelamer Price by Manufacturers
- 3.4 Key Manufacturers Sevelamer Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Sevelamer Market
- 3.6 Key Manufacturers Sevelamer Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Tablet Sales and Revenue (2014-2019)
- 4.1.2 Oral suspension Sales and Revenue (2014-2019)
- 4.2 Global Sevelamer Sales Market Share by Type
- 4.3 Global Sevelamer Revenue Market Share by Type
- 4.4 Sevelamer Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Sevelamer Sales by Application
6 United States
- 6.1 United States Sevelamer Breakdown Data by Company
- 6.2 United States Sevelamer Breakdown Data by Type
- 6.3 United States Sevelamer Breakdown Data by Application
7 European Union
- 7.1 European Union Sevelamer Breakdown Data by Company
- 7.2 European Union Sevelamer Breakdown Data by Type
- 7.3 European Union Sevelamer Breakdown Data by Application
8 China
- 8.1 China Sevelamer Breakdown Data by Company
- 8.2 China Sevelamer Breakdown Data by Type
- 8.3 China Sevelamer Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Sevelamer Breakdown Data by Company
- 9.2 Rest of World Sevelamer Breakdown Data by Type
- 9.3 Rest of World Sevelamer Breakdown Data by Application
- 9.4 Rest of World Sevelamer Breakdown Data by Countries
- 9.4.1 Rest of World Sevelamer Sales by Countries
- 9.4.2 Rest of World Sevelamer Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sanofi
- 10.1.1 Sanofi Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Sevelamer
- 10.1.4 Sevelamer Product Introduction
- 10.1.5 Sanofi Recent Development
- 10.2 Impax Laboratories
- 10.2.1 Impax Laboratories Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Sevelamer
- 10.2.4 Sevelamer Product Introduction
- 10.2.5 Impax Laboratories Recent Development
- 10.3 InvaGen Pharmaceuticals
- 10.3.1 InvaGen Pharmaceuticals Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Sevelamer
- 10.3.4 Sevelamer Product Introduction
- 10.3.5 InvaGen Pharmaceuticals Recent Development
- 10.4 Dr. Reddy's Laboratories
- 10.4.1 Dr. Reddy's Laboratories Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Sevelamer
- 10.4.4 Sevelamer Product Introduction
- 10.4.5 Dr. Reddy's Laboratories Recent Development
- 10.5 Aurobindo Pharma
- 10.5.1 Aurobindo Pharma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Sevelamer
- 10.5.4 Sevelamer Product Introduction
- 10.5.5 Aurobindo Pharma Recent Development
- 10.6 Amneal Pharmaceuticals
- 10.6.1 Amneal Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Sevelamer
- 10.6.4 Sevelamer Product Introduction
- 10.6.5 Amneal Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Sevelamer Sales Channels
- 11.2.2 Sevelamer Distributors
- 11.3 Sevelamer Customers
12 Market Forecast
- 12.1 Global Sevelamer Sales and Revenue Forecast 2019-2025
- 12.2 Global Sevelamer Sales Forecast by Type
- 12.3 Global Sevelamer Sales Forecast by Application
- 12.4 Sevelamer Forecast by Regions
- 12.4.1 Global Sevelamer Sales Forecast by Regions 2019-2025
- 12.4.2 Global Sevelamer Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Sevelamer. Industry analysis & Market Report on Sevelamer is a syndicated market report, published as Global (United States, European Union and China) Sevelamer Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Sevelamer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
